Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
暂无分享,去创建一个
S. Kernéis | F. Barbier | J. Zahar | O. Pajot | J. Poissy | D. Roux | S. Hraiech | Nathanaël Veluppillai